Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial.

By Jeannie K. Lee, K. Grace, Allen J. Taylor. Journal of the American Medical Association (JAMA), 2006

883 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Family Practice, Geriatrics and Gerontology

View Paper: https://www.semanticscholar.org/paper/1312da383b480293b80095c19a270f4aa1f58018

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

In Family Practice

In Geriatrics and Gerontology

Citations in the corpus

Interventions to Improve Adherence to Self-administered Medications for Chronic Diseases in the United States (2012, background): “For hypertension, both case management (96, 111, 112) and face-to-face education by pharmacists (109, 116, 117) led to enhanced adherence that decreased systolic and diastolic blood pressure.”
ESH / ESC Guidelines for the management of arterial hypertension (2013, background): “Low adherence is extremely common for lifestyle changes but importantly extends to drug prescriptions, for which it develops quite rapidly: after 6 months, more than one-third and after 1 year about half of the patients may stop their initial treatment; furthermore, on a daily basis, 10% of patients”
Medication adherence: WHO cares? (2011, background): “” Among patients with chronic illness, approximately 50% do not take medications as prescribed.(1,2) This poor adherence to medication leads to increased morbidity and death and is estimated to incur costs of approximately $100 billion per year.”
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2007, background): “Overall, three main causes of the low rate of BP control in real life have been identified: (i) physician inertia [703]; (ii) patient low adherence to treatment [704,705], and (iii) deficiencies of healthcare systems in their approach to chronic diseases.”
Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. (2007, background): “The beneficial biological effects associated with higher drug adherence on survival underscores the need to optimize adherent patient behavior patterns to maximize the survival gains of evidence-based therapies in real-world populations, which may be enhanced through the implementation of pharmacy o”